In the spirit of shameless promotion, we answer that question: Purchase and listen to our webinar of that very title, coming up on Thursday, Oct. 22. Avoid extinction by learning how to stay in compliance and out of trouble with experts from Parexel Consulting.
Early bird pricing ends after Oct. 15. Get all the info and register HERE.
Or first read a few thoughts from our marketing department about why this is a must-attend webinar:
FDA Commissioner Margaret Hamburg has announced new initiatives to streamline and speed up the enforcement process. Within this, the requirements for compliance have not changed. What has changed is the promptness with which FDA will react to violative findings during inspections. Past delays in the implementation of enforcement actions have provided time for companies to make corrections – with re-inspections often conducted before actions are taken. Not so anymore.
This presentation will highlight those areas that should be given constant emphasis by pharma companies to avoid the need for FDA enforcement actions, pro-activities that should be carried out during an FDA inspection, and strategies to manage post-inspection activities.
Here’s a sample of what you’ll learn during the 90-minute audio conference:
* The new initiatives announced thus far by Commissioner Hamburg
* How they impact you
* How to prepare for your FDA inspections with these changes in mind
* The best way to respond and manage post-inspection processes
* How you can implement a compliance-focused culture in your organization
... and much more!
The discussion will be delivered in a convenient audio conference format, and capped off with an interactive Q&A round.
So join us, in the convenience of your own office, for a thought-provoking analysis. Grab your team (or several teams), a conference room, a phone and a computer with Web access (that last one's optional). No travel required. Register now!
